|
2026
|
P/S
|
Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of... |
|
|
Invention
|
Method for predicting the off-target binding of a peptide which binds to a target peptide present... |
|
2025
|
Invention
|
Specific binding molecules. The present invention relates to antibodies which bind to CD3, partic... |
|
|
Invention
|
Intravenous solution stabilizer. The present disclosure provides a method of administering a low ... |
|
|
Invention
|
Tcr-anti-cd3 antibody fusion molecule for the treatment of hiv infection. The present invention r... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of viral infections; biological preparations for th... |
|
|
Invention
|
Screening methods. The invention relates to screening methods. In particular, it relates to a met... |
|
|
Invention
|
Method of treating cancer using a gene expression signature. The present disclosure provides a me... |
|
|
Invention
|
Half-life extended immtac binding cd3 and a hla-a*02 restricted peptide.
The present invention r... |
|
|
Invention
|
Method of treating prame-positive cancer. The present disclosure provides a method of treating no... |
|
|
Invention
|
Multi-domain binding molecules.
The present invention relates to multi-domain, single-chain bind... |
|
|
Invention
|
Multi-domain molecules.
The present disclosure provides multi-domain molecules comprising, (i) a... |
|
|
Invention
|
Cd1a-pd-1 bispecific agonist for the treatment of atopic dermatitis. The present disclosure provi... |
|
2024
|
Invention
|
Bispecific molecules. The present invention provides bispecific molecules comprising a soluble TC... |
|
|
Invention
|
Binding molecules.
The present invention relates to binding molecules that comprise T cell recep... |
|
|
Invention
|
Method for purifying small multi-domain proteins. The present disclosure provides a method for pu... |
|
|
Invention
|
Method for purifying small multi-domain proteins |
|
|
Invention
|
Peptide-hla binding molecules |
|
|
Invention
|
Peptide-hla binding molecules. The present invention relates generally to binding molecules compr... |
|
|
P/S
|
Educational services, namely, providing information online or in person in the field of tumorous ... |
|
|
P/S
|
Pharmaceutical preparations, biological preparations and
bispecific reagents for the treatment o... |
|
|
P/S
|
Pharmaceutical preparations and biological preparations containing bispecific T-cell receptors fo... |
|
|
Invention
|
Method of treating cutaneous melanoma |
|
|
Invention
|
Method of treating cutaneous melanoma. The present disclosure provides a method of treating cutan... |
|
|
Invention
|
Hiv specific binding molecules and uses thereof.
Specific binding molecules, including T cell re... |
|
|
P/S
|
Pharmaceutical testing; scientific research in the nature of conducting clinical trials for other... |
|
|
Invention
|
Treatment of mage-a4 positive cancer.
Methods are presented for the administration of a TCR-anti... |
|
|
Invention
|
T cell receptors.
The present invention relates to T cell receptors (TCRs) that bind the HLA-A*0... |
|
|
Invention
|
Tcr with high affinity and specificity specific for preproinsulin peptide alwgpdpaaa bound to hla... |
|
|
P/S
|
Pharmaceutical preparations; biological preparations for the treatment of autoimmune diseases; bi... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune diseases; biological preparations for... |
|
|
Invention
|
Binding molecules. The present invention relates to binding molecules that comprise T cell recept... |
|
|
Invention
|
Binding molecules against a prame peptide-hla complex |
|
|
Invention
|
Binding molecules against a piwil1 peptide-hla complex |
|
|
Invention
|
Binding molecules against a piwil1 peptide-hla complex. The present invention relates to binding ... |
|
|
Invention
|
Binding molecules against a prame peptide-hla complex. The present invention relates to binding m... |
|
2023
|
Invention
|
T cell receptors and fusion proteins thereof. The present disclosure provides T cell receptor (TC... |
|
|
Invention
|
Compositions and methods for treating cancer that demonstrates decreasing levels of ctdna in a su... |
|
|
Invention
|
Multi-domain binding molecules.
The present invention relates to multi-domain binding molecules.... |
|
|
Invention
|
Multi-domain binding molecules |
|
|
Invention
|
Multi-domain binding molecules. The present invention relates to multi-domain binding molecules. ... |
|
|
Invention
|
Multi-domain binding molecules. The present invention relates to multi-domain, single-chain bindi... |
|
|
Invention
|
T cell receptors and fusion proteins thereof.
The present disclosure provides T cell receptor (T... |
|
|
Invention
|
T cell receptor fusion proteins specific for mage a4 |
|
|
Invention
|
T cell receptor fusion proteins specific for mage a4. The present disclosure provides T cell rece... |
|
|
Invention
|
Methods of treating melanoma using tebentafusp and immune checkpoint inhibitors.
The present inv... |
|
2022
|
Invention
|
Treatment.
Methods are presented for the administration of a TCR-anti-CD3 fusion molecule to tre... |
|
2021
|
Invention
|
Specific binding molecules.
The present invention relates to specific binding molecules which bi... |
|
|
P/S
|
Business administration services in the field of healthcare; patient relationship management serv... |
|
|
P/S
|
Pharmaceutical preparations, biological preparations and bispecific biological reagents for medic... |
|
|
P/S
|
Pharmaceutical preparations; biological preparations for the
treatment of cancer; biological pre... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer, viral infections, autoimmune diseases, a... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer, viral infections, and tumorous diseases;... |
|
|
P/S
|
Pharmaceutical preparations; biological preparations for the treatment of cancer; biological prep... |
|
|
P/S
|
Pharmaceutical preparations excluding ophthalmic pharmaceutical preparations; biological preparat... |
|
2020
|
Invention
|
Specific binding molecules.
The present invention relates to specific binding molecules, such as... |
|
2019
|
P/S
|
Pharmaceutical preparations for the treatment of cancer, tumerous diseases, infectious diseases a... |
